CZ 112
Alternative Names: 9-Nitrocamptothecin propionate; Rubitecan prodrugLatest Information Update: 20 Apr 2011
Price :
$50 *
At a glance
- Originator The Stehlin Foundation for Cancer Research
- Developer SuperGen
- Class Antineoplastics; Camptothecins; Small molecules
- Mechanism of Action DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer